アメリカの臨床化学検査市場動向(~2021)

◆英語タイトル:United States Clinical Chemistry Market Outlook to 2021
◆商品コード:GDMECC1201DB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年8月7日
◆ページ数:63
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

United States Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, “United States Clinical Chemistry Market Outlook to 2021″, provides key market data on the United States Clinical Chemistry market. The report provides value, in millions of US dollars within market segments – Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the United States Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Clinical Chemistry Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Clinical Chemistry Market, United States 9
3.1 Clinical Chemistry Market, United States, Revenue ($m), 2007-2014 9
3.2 Clinical Chemistry Market, United States, Revenue ($m), 2014-2021 11
3.2.1 Clinical Chemistry Analyzers Market, United States, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Urine Analysis Market, United States, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Therapeutic Drug Monitoring Market, United States, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Clinical Chemistry Analyzers Market, United States, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Urine Analysis Market, United States, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Therapeutic Drug Monitoring Market, United States, Revenue ($m), by Segment, 2014-2021 23
3.3 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014 25
3.4 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2014 26
4 Overview of Key Companies in United States, Clinical Chemistry Market 28
4.1 Siemens Healthcare 28
4.1.1 Company Overview 28
4.2 Abbott Laboratories 28
4.2.1 Company Overview 28
4.3 F. Hoffmann-La Roche Ltd. 28
4.3.1 Company Overview 28
4.4 Danaher Corporation 29
4.4.1 Company Overview 29
4.5 Ortho-Clinical Diagnostics Inc. 29
4.5.1 Company Overview 29
4.6 bioMerieux S.A. 29
4.6.1 Company Overview 29
4.7 Bio-Rad Laboratories, Inc. 30
4.7.1 Company Overview 30
5 Clinical Chemistry Market Pipeline Products 31
6 Financial Deals Landscape 34
6.1 Acquisition 34
6.1.1 Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 34
6.1.2 Quest Diagnostics May Sell itself 37
6.1.3 LabCorp Acquires Covance for USD6.1 Billion 38
6.2 Debt Offerings 40
6.2.1 Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 40
6.2.2 LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 42
6.2.3 LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 44
6.2.4 LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 46
6.2.5 LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 48
6.2.6 Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 50
6.2.7 Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 52
6.3 Partnerships 54
6.3.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 54
6.3.2 Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 55
6.4 Venture Financing 56
6.4.1 Rubicon Genomics Raises USD2 Million in Venture Financing 56
6.4.2 Atomwise Raises USD6 Million in Seed Financing 58
6.4.3 Lucigen Raises USD2.2 Million in Venture Financing 59
7 Appendix 60
7.1 Research Methodology 61
7.1.1 Coverage 61
7.1.2 Secondary Research 61
7.1.3 Primary Research 61
7.1.4 Company Share Analysis 62
7.1.5 Distribution Share Analysis 62
7.2 GlobalData Consulting 62
7.3 Contact Us 62
7.4 Disclaimer 63

1.1 List of Tables
Table 1: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25
Table 10: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014 27
Table 11: Clinical Chemistry Market Pipeline Products 31
Table 12: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 34
Table 13: Quest Diagnostics May Sell itself 37
Table 14: LabCorp Acquires Covance for USD6.1 Billion 38
Table 15: Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 40
Table 16: LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 42
Table 17: LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 44
Table 18: LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 46
Table 19: LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 48
Table 20: Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 50
Table 21: Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 52
Table 22: NoemaLife Enters into Distribution Agreement with Horiba Medical 54
Table 23: Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 55
Table 24: Rubicon Genomics Raises USD2 Million in Venture Financing 56
Table 25: Atomwise Raises USD6 Million in Seed Financing 58
Table 26: Lucigen Raises USD2.2 Million in Venture Financing 59

1.2 List of Figures
Figure 1: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Clinical Chemistry Market, United States, Company Share (%) 2014 26

【掲載企業】

Siemens Healthcare
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アメリカの臨床化学検査市場動向(~2021)(United States Clinical Chemistry Market Outlook to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆